Matrix Pharmacorp Private Limited
⚠️ Moderate Risk
FEI: 3008861594 • Visakhapatnam, Andhra Pradesh • INDIA
FEI Number
3008861594
Location
Visakhapatnam, Andhra Pradesh
Country
INDIAAddress
Plot No. 5, Unit 9, Anakapalli District, Visakhapatnam, Andhra Pradesh, India
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/17/2020 | 62VDA99ANTI-VIRAL N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/15/2020 | 62VCA15TENOFOVIR DISOPROXIL FUMERATE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/13/2020 | 62VCA15TENOFOVIR DISOPROXIL FUMERATE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/13/2020 | 62VBT15TENOFOVIR DISOPROXIL FUMERATE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/17/2020 | 62VDY15TENOFOVIR DISOPROXIL FUMERATE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is Matrix Pharmacorp Private Limited's FDA import refusal history?
Matrix Pharmacorp Private Limited (FEI: 3008861594) has 5 FDA import refusal record(s) in our database, spanning from 3/17/2020 to 4/17/2020.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Matrix Pharmacorp Private Limited's FEI number is 3008861594.
What types of violations has Matrix Pharmacorp Private Limited received?
Matrix Pharmacorp Private Limited has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Matrix Pharmacorp Private Limited come from?
All FDA import refusal data for Matrix Pharmacorp Private Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.